Surgical therapy for severe intraabdominal infection (secondary peritonitis)
- Conditions
- K35.2K57.0K57.2Peritonitis, unspecifiedK65.0Acute peritonitisDiverticular disease of small intestine with perforation and abscessDiverticular disease of both small and large intestine with perforation and abscessDiverticular disease of large intestine with perforation and abscessK65.9
- Registration Number
- DRKS00016165
- Lead Sponsor
- Chirurgische AbteilungSMZ Ost - Donauspital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 197
All patients treated at an intensive care units at the Sozialmedizinisches Zentrum Ost - Donauspital (DSP) from 2010 to 2018 due to a secondary peritonitis detected during surgery.
This includes all surgically treated patients with secondary peritonitis from the age of 18.
Patients without evidence of secondary peritonitis, younger than 18 years of age and/or without treatment in intensive care are excluded from the study.
Patients who refuse to participate in the study will also be excluded.
Patients who are not interested in a follow-up or a telephone interview are not included in the long-term results.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary objective of the study is to create a comprehensive database on the clinical course, risk profile and outcome of patients with secondary peritonitis who needed intensive care in the DSP (Sozialmedizinisches Zentrum Ost – Donauspital). <br>
- Secondary Outcome Measures
Name Time Method - Value of prognostic parameters in patients with postoperative peritonitis (POP) in comparison with outpatient (community) acquired peritonitis (CAP)<br>- Comparison of development of microbeal resistance between outpatient acquired intraabdominal infection and postoperative peritonitis with open abdomen<br>- Effects on the clinical course of the development of enteroatmospheric fistulas after severe intraabdominal infections<br>- Long-term outcomes and quality of life (SF-36)